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report
Childhood Cancer Mortality in India:
Direct Estimates From a Nationally
Representative Survey of Childhood
Deaths
abstract
Purpose Although most children with cancer live in low- and middle-income countries, measurements of
childhood cancer burden in such countries have been restricted to incidence rates from a few subnational
cancer registries andmortality rates from vital statistics.We aimed to provide alternative burden estimates
by using nationally representative longitudinal survey–derived mortality rates.
MethodsWeexaminedcancer deaths in childhood (1month to14years of age) in theMillion DeathStudy, a
cohort of > 27,000 pediatric deaths in India on the basis of enhanced verbal autopsies. All deaths po-
tentially due to childhood cancer were identified. Two pediatric specialists independently categorized
deaths as definite, probable, possible, or unlikely cancer related. From definite and probable deaths, we
estimated national and regional mortality rates attributable to childhood malignancies. Data on symptoms
and health care–seeking behavior were abstracted from closed-ended questions and caregiver narratives.
Results Of 700 included deaths, 189 were classified as definite or possibly cancer related. Thek-statistic
between reviewerswas0.75 (95%CI, 0.71 to0.78). From thesedeaths,weestimated that in 2010,13,700
were a result of childhood cancer in India, which led to amortality rate of 37 (95%CI, 31 to 42) per million
population per year, which exceeds many prior estimates of mortality and even some estimates of in-
cidence. Disparities between mortality estimates were widest in northeast India and for brain tumors. A
preponderance of male deaths was seen (male:female ratio, 1.6:1).
Conclusion The burden of childhood cancer in India is substantially higher than previously suggested. This
information will aid advocacy for national strategies aimed at improving outcomes for Indian children with
cancer.
J Glob Oncol 2. © 2016 by American Society of Clinical Oncology Licensed under the Creative Commons Attribution 4.0 License
INTRODUCTION
Significant progress has been made in the treat-
ment of pediatric cancer;. 80%of children inhigh-
income countries (HICs) now achieve 5-year
survival.1,2 These advances have not been fully re-
alized in low- andmiddle-incomecountries (LMICs),
where themajority of children with cancer reside.3,4
A major impediment to improving LMIC pediatric
oncology outcomes is the paucity of data on the true
burden of childhood cancer in these settings.5 This
deficit hampers efforts to place childhood cancer on
LMIC public health agendas and hinders the design
and implementation of effective national childhood
cancer strategies.5
In HICs, pediatric cancer incidence rates are
determined by high-quality population-based
cancer registries, whereas cancer mortality
rates are usually determined through systems
of death registration or vital statistics.2 Link-
ages between these two data sources provide a
more complete picture of the cancer burden
in a population. Estimations in LMICs is prob-
lematic given the paucity of registries and vital
statistics. For example, in 2006, population-
based cancer registries covered only 8% of
populations in Asia and 11% in sub-Saharan
Africa; when only high-quality registries are
considered, proportions were 5% and 2%, re-
spectively.6 Even where high-quality registries
exist, poor access to health care and diagnos
tic tools may still result in substantial under-
estimates of the actual incidence rates of child-
hood cancer. Where systems of death registrations
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exist, deaths still may be unreported and cause
of death data lacking.7
We aimed to estimate the burden of childhood
cancer in a specific LMIC (India) by using a meth-
odology that focused on childhood cancer mor-
tality and did not depend on cancer registries or
vital statistics data bases. We used verbal autopsy
reports from the Million Death Study (MDS), a
unique,nationally representative, and longitudinal
survey of . 14 million people.
METHODS
Million Death Study
Details of the MDS design, statistical and epi-
demiologic methods, and preliminary results
pertaining to overall cancer mortality have been
reported elsewhere.8,9 In brief, as part of the
overall MDS, the Registrar General of India
introduced a detailed verbal autopsy instrument
into its nationally representative Sample Regis-
tration System (SRS) as a part of generating
national vital statistics. The SRS comprised
6,671 small areas randomly chosen from ap-
proximately 1 million areas delineated by the
1991 census, each in turn comprising approx-
imately 1,000 individuals. All individuals within
the chosen areaswere enumerated; subsequent
births and deathswere documented everymonth
by a local part-time enumerator and indepen-
dently surveyed twice a year by one of 800
full-time Registrar General of India supervisors
(nonmedical graduates). Deaths were docu-
mented between 2001 and 2003 and then be-
tween 2004 and 2014 in a new SRS sampling
frame. Each surveyor who visited an SRS area
recorded from appropriate informants a written
narrative in the local language that described
events preceding thedeath in addition to closed-
ended questions related to key symptoms. Sepa-
rate instruments were used for deaths in children
age 1 month to 14 years on the basis of a World
Health Organization multicountry validation study
of verbal autopsy for commoncauses of childhood
death.10
For each MDS death, each local language narra-
tive and corresponding symptom data were
electronically scanned and sent to two of 130
collaborating physicians trained in disease cod-
ing. These physicians independently assessed
the most likely underlying cause of death by
assigning a three-character code from the Inter-
national Classification of Diseases, Tenth Revision
(ICD-10).11 Disagreements were resolved by anon-
ymous reconciliation; a third senior physician ad-
judicated persistent differences.
Identification of Deaths as a Result of Childhood
Cancer
We aimed to identify all pediatric (age 0 to 14
years) deaths due to malignancy reported in the
MDS between 2001 and 2003. First, all MDS
deaths that potentially resulted from childhood
cancer were assembled by identifying those that
met at least one of the following three criteria: final
cause of death attributed to cancer, final cause of
death attributed to a nonmalignant cause post-
reconciliation despite being attributed to cancer
by one of the two initial assessing physicians, and
nonmalignant causes of death a priori identified
as difficult to differentiate from malignant causes
by verbal autopsy. This latter criteria included the
following causes of death: epilepsy (ICD-10 G40),
neurologic deficits (ICD-10 R56), anemia (ICD-10
D50 to D64), sepsis or fever of unknown origin
(ICD-10 A41, R50) if accompanied by pallor, and
nutritional or ill defined (ICD-10 R96, R99) if
accompanied by fever. Deaths within the first
month of life were excluded given the rarity of
cancer and high prevalence of infectious and
congenital causes of mortality in this population.
Both the narratives of events that led to death and
the closed-ended questions on symptoms, risk
factors, disease history, and demographic char-
acteristics were retrieved for all deaths that met
these criteria. Professional translators translated
the narratives into English. A pediatric oncologist
(S.G.) and pediatric infectious disease specialist
(S.K.M.) independently reviewed and classified
each cause of death into one of four categories:
definitecancer (provenbydiagnostic testing),prob-
able cancer (likely given clinical description and
epidemiology but unproven by diagnostic testing),
possible cancer (possible given clinical description
and epidemiology but other nonmalignant causes
also likely), and unlikely or definitely not cancer
(other nonmalignant causes likely or confirmed by
diagnostic testing). Reviewers were blinded to the
original causes of death assigned in the MDS.
Discrepancies were resolved through discussion.
Agreement was assessed by using the k statistic.12
Subsequent analyses were restricted to definite
or probable deaths from cancer. Several data
variables were abstracted from the narratives,
which included symptom duration, type of treat-
ment received, note of caregiver financial diffi-
culties, and location of death. The highest level of
health care accessed was also abstracted, with
hospital-based care superseding care delivered
by local health care workers. Hospitals were
categorized as governmental, private, or other/
unknown.
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Estimation of Total Number of Pediatric Cancer
Deaths
The absolute number of deaths from cancer in
childhood at a national level was derived by ap-
plying age- and sex-specific proportions of pedi-
atric cancer deaths in the 2001 to 2003 MDS to
2010 United Nations estimates of all-cause pedi-
atric deaths in India.13-16 These estimates were
chosen due to proximity to the 2011 census.
Despite census data that referred to population
counts and not deaths, this estimate allowed us
to correct for slight undercounts in total SRS-
reported death rates. This correction process
has been described previously.17 As reported pre-
viously, deathsmissed by theMDS (approximately
12%) were due to family outmigration or from
incomplete field records.18 Total pediatric deaths
were portioned into region-specific total deaths by
using the relative SRS pediatric deaths for 2007 to
2009.19 The age-sex–specific proportion of pedi-
atric cancer deaths to total pediatric deaths in the
current survey were weighted for the sampling
probability of population selection for each rural
or urban stratum per state, although such weight-
ing made little difference because the study was
nationally representative. Crudemortality ratesper
million population were calculated. Rates were
standardized to the world population for compar-
ison with other estimates.20
SRS enrollment was voluntary, and its confiden-
tiality and consent procedures are defined as part
of the Registration of Births andDeaths Act, 1969.
Oral consent was obtained in the first SRS sample
frame. Families were free to withdraw from the
study; compliance was nonetheless . 95%. The
study was approved by the review boards of the
Post-Graduate Institute of Medical Education and
Research, St Michael’s Hospital, and the Indian
Council of Medical Research. Statistical analyses
were performed with SAS version 9.4 software
(SAS Institute, Cary, NC).
RESULTS
A total of 700 deaths met initial MDS inclusion
criteria: 212 attributed to cancer, 20 to a final
nonmalignant cause by reconciliation or adjudi-
cation despite one reviewing physician’s attribu-
tion to cancer, and 468 to causes of death or
symptoms similar to a potential malignancy. After
categorization and resolution of discrepancies,
189 deaths were classified as either definitely
(n = 109) or probably (n = 80) a result of cancer.
These 189 deaths comprised the final study co-
hort. Eighty-five deaths were categorized as pos-
sibly cancer related, with the remaining 426
classified as unlikely or definitely not cancer re-
lated. The weighted k between the two reviewers’
categorizations was 0.75 (95% CI, 0.71 to 0.78).
The flow of case selection is illustrated in Figure 1.
Forty-nine deaths originally attributed to cancer by
the MDS were categorized as either possibly or
unlikely/definitely not cancer; 26 deaths originally
attributed as nonmalignant causes by the MDS
were categorized as definitely or probably cancer
related. The most common causes were fever of
other andunknownorigin (n=6 [23%]), ill defined
and unspecified (n = 5 [19%]), and other anemias
(n = 5 [19%]). The full list of MDS-attributed
causes of death for these 26 patients are shown
in the Data Supplement. The demographic char-
acteristics of the final study cohort are listed in
Table 1.
A total of 13,700 (95% CI, 11,800 to 15,700)
pediatric cancer deaths were estimated in India
in 2010. The national rate of pediatric cancer
deaths was 37 (95% CI, 31 to 42) per million
population. When standardized according to the
world standard population for children age 0 to
14 years, a mortality rate of 39 (95% CI, 33 to 44)
per million population was obtained. Regional
deaths and cancer mortality rates are illustrated
in Figure 2. The number of study deaths and
corresponding national-level death estimates
and mortality rates by cancer subgroups are
shown inTable2.Comparisons to selected Indian
and HIC population-based cancer registries are
shown in Table 3.
A total of 158 (83.4%) MDS patients experienced
symptoms preceding death for . 1 month’s du-
ration. Some level of health care was received by
183 (96.8%) patients before death (Table 4).
Treatment of any form was received by 153
(81.0%) patients. The delivery of blood products
wasnoted in28 (14.8%)patients andantibiotics in
19 (10.1%). Cancer-directed therapy was rarely
delivered: Only 36 (19.0%) narratives noted the
receipt of surgery, eight (4.2%) the receipt of
chemotherapy, and three (1.6%) the receipt of
radiation. One hundred eleven (58.7%) narratives
noted thedeliveryof somemedical therapywithout
further detail. Traditional or alternative therapy
was noted in 16 (8.5%) patients and financial
difficulties in 19 (10.1%). Death occurred at home
in the majority of narratives (n = 109 [57.7%]). A
further 49 (25.9%) deaths occurred in health care
facilities, although one (0.5%) occurred en route
to thehospital. The location of deathwas unknown
in the remaining 30 (15.9%) narratives. No sig-
nificant differences were found by sex in symptom
duration (. 1 month: boys, 95 of 116 [81.8%];
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girls, 63 of 72 [(87.5%]; P = .31), receipt of any
treatment (boys, 96 of 117 [82.1%]; girls, 57 of
72 [79.2%]; P = .62], or location of death (deaths
at home: boys, 68 of 97 [70.1%]; girls, 41 of
61 [67.2%]; P = .70).
DISCUSSION
By using verbal autopsies from a nationally rep-
resentative cohort and a rigorous process of reas-
sessment of the causes of death, we aimed to
characterize the burden of childhood cancermor-
tality in India. We found highermortality rates than
reported in the past and, in some instances, that
evenexceededestimates of incidenceprovidedby
population-based cancer registries. Although this
may reflect true differences between the national
mortality rate and rates in specific smaller geo-
graphic areaswith nonrepresentativepopulations,
underdiagnosis and under-registration are also
likely to play a role.
We determined an overall age-standardized mor-
tality ratedue to pediatric cancer of 39 (95%CI, 33
to 44) per million population per year. This rate is
higher than those reported frommost jurisdictions
(Table 3). This disparity was most pronounced in
certain malignancies and in certain regions. For
CNS tumors, the MDS-derived mortality rate was
nine per million population per year, a rate dis-
tinctly higher than even the incidence rates re-
ported by several cancer registries. Explanatory
factors include the difficulty in diagnosing CNS
tumors without expensive diagnostic modalities,
such as computed tomography scans, and the
variation between registries in their inclusion of
benignCNSmalignancies.Combining information
from six local administrative areas, the Indian
Council of Medical Research reported a mortality
rate attributable to childhood cancer in northeast
India of 19 per million population per year.21 The
equivalent MDS-derived rate for the northeast re-
gion ismore than twice ashighat 39 (95%CI, 18 to
60) per million population.
Even where high-quality cancer registries exist,
multiple steps are required to capture pediatric
cancer diagnoses.25 Caregivers must seek med-
ical attention, and health care workers must refer
patients to tertiary centers capable of diagnosing
malignancies. Only upon a correct cancer diag-
nosis cana tertiary center register thepatient case.
Vital statistics depend on similar steps. Breaks in
this chain of events may occur at any step, which
leads to underestimates of true incidence or mor-
tality rates.25 Such underestimates are likely to be
substantial in settings with barriers to accessing
high-quality health care. These issues have been
noted not only in India but also across various
LMICs.26,27
Our methodology that used MDS data overcomes
many, but not all of these limitations. First, given
the nationally representative sampling of theMDS,
national estimates of childhoodcancer burdenare
possible. Second, all causes of death, in addition
to cancer, are captured. Consequently, the MDS-
based analyses will have captured several groups
of children with cancer missed by cancer regis-
tries: those with confirmed malignancies diag-
nosed at facilities that do not report to registries
and those whose signs and symptoms were a
result of a malignancy but who did not undergo
diagnostic testing. Efforts to capture this latter
Cause of death and/or
symptom complex suspicious
for underlying cancer
(n = 468)
Deaths attributed by the
MDS to noncancer cause
despite cancer attribution by
one physician assessor
(n = 20)
Deaths potentially attributable to
childhood cancer
(n = 700)
Final study cohort
(N = 189)
Possible
(n = 85)
Unlikely
(n = 426)
Probable
(n = 80)
Definite
(n = 109)
Deaths attributed by the
MDS to cancer
(n = 212)
Fig 1 –
Identification of Million
Death Study (MDS) deaths
attributable to childhood
cancer.
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group included both the initial review of verbal
autopsies by MDS physicians and the indepen-
dent re-review of candidate deaths by two pedia-
tric specialists. This resulted in the reclassification
of a small, but significant number of deaths.
Despite this rigorous re-review,misclassificationof
deaths is still certain to have played a role in the
current analyses. Such misclassification is of par-
ticular concern in hematologic malignancies, in
which the presenting symptoms (fever, malaise,
hemorrhage) have substantial overlap with those
of more common, infectious causes of death.
Other authors have noted that disparities in
registry-derived incidence rates of pediatric leu-
kemia between LMICs and HICs are wider than
when comparing the incidence of more recogniz-
able tumors that present with, for example, en-
larging masses.25 Despite these limitations, these
figures are, to our knowledge, the most nationally
representative derived from primary data in India
to date. With an appropriate degree of uncertainty
because of the possibility of misclassification,
these figures suggest a burden of childhood can-
cer mortality in India that is substantially higher
than previously reported.
Several additional findings merit discussion. First,
themale to female ratio among deaths attributable
to childhood cancer was 1.6:1. By contrast, pre-
vious MDS analyses of childhood mortality have
identified amarked excess of female deaths.14 For
example, death as a result of both diarrheal dis-
eases and pneumonia was nearly 50% higher in
girls than in boys, whereas measles deaths were
nearly 70% greater in girls than in boys.15,16 This
preponderance of female deaths has been attrib-
uted to the impact of sex preferences on health
care–seeking behavior; previous studies have
shown a correlation between areas with higher
excess mortality rates among young girls and
those with lower female:male sex ratios for second
births after a boy, a marker of the presence of sex-
selective abortion.14,28 The same phenomenon is
likely responsible for the male preponderance
seen in the current study. Preferentially accessing
health care for boys may lead to lower mortality
rates for conditions where treatment is both rela-
tively simple to deliver and effective (eg, diarrheal
diseases). In settings where childhood cancer
treatment is limited or unavailable, the same sex-
based health care–seeking preference for cancer
may lead to an increased probability of a correct
cancer diagnosis being made without increasing
the probability of cure.
Second, the MDS verbal autopsy narratives in-
dicated that the duration of symptoms experi-
enced by cohort patients exceeded 1 month in
. 80% of deaths. This finding supports previous
conjecture that delayed diagnosis is a significant
issue in LMIC children with cancer.29 Although
the impact of prolonged times to diagnosis in HICs
is still under debate, previous authors have sug-
gested that they represent a major barrier to cure in
LMICs, which results in advanced stage and poor
performance status at diagnosis.29-31 Similarly,
Table 1 – Characteristics of Final Cohort of Million Death Study Deaths Categorized as
Childhood Cancer Related
Childhood Cancer–Related Death, No. (%)
Definite or Probable
(n = 189)
Definite
(n = 109)
Age at death
1-59 months 82 (43) 45 (41)
5-9 years 45 (24) 27 (25)
10-14 years 62 (33) 37 (34)
Sex
Male 117 (62) 69 (63)
Female 72 (38) 40 (37)
Urban v rural
Urban 29 (15) 21 (19)
Rural 160 (85) 88 (81)
Geographic location
East 57 (30) 30 (28)
Central 49 (26) 29 (27)
West 25 (13) 17 (16)
South 23 (12) 15 (14)
North 22 (12) 11 (10)
Northeast 13 (7) 7 (6)
Location of death
Home 128 (68) 69 (63)
Heath care facility 47 (25) 33 (30)
Other 14 (7) 7 (6)
Malignancy type
Leukemia/lymphoma 94 (50) 53 (49)
Leukemia 66 (35) 43 (40)
Lymphoma 27 (14) 10 (9)
Unknown 1 (0.5) 0 (0)
Solid tumor 49 (26) 26 (24)
Neuroblastoma 4 (2) 2 (2)
Wilms tumor 1 (0.5) 1 (1)
Sarcoma 17 (9) 8 (7)
Retinoblastoma 5 (3) 5 (5)
Unknown/other 22 (12) 10 (9)
CNS tumor 46 (24) 30 (28)
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although nearly all of the MDS cohort (96.8%)
accessed some level of health care, only a small
number received any cancer-directed therapy.
Though thesenumbers should be consideredwith
caution given their dependence on open-ended
caregiver narratives and the inability to generalize
them to childrenwho experienced cure (see next),
they nonetheless provide a first population-based
lookat the trajectoryexperiencedbyLMICchildren
who succumb to cancer.
Third, although the ability of verbal autopsies and
multiple independent physician coders to identify
major causes of death correctly has been estab-
lished in both adults and children,10,32 the iden-
tification of uncommon causes ofmortalitymay be
more difficult. Our technique, which involved cen-
tral re-review of deaths by the appropriate special-
ist physicians, represents a method by which rare
causes of deathmay bemore accurately captured
and thus extends the utility of verbal autopsies.
Central
Mortality rate = 32 (23-41)
  Girls = 22 (11-32)
  Boys = 42 (28-56)
Deaths = 4,337
  Girls = 1,369
  Boys = 2,969
West
Mortality rate = 35 (21-49)
  Girls = 14 (3-26)
  Boys = 54 (30-78)
Deaths = 1,761
  Girls = 341
  Boys = 1,420
India Totals
Mortality rate = 37 (23-50)
  Girls = 28 (22-35)
  Boys = 44 (36-52)
Deaths = 13,725
  Girls = 5,079
  Boys = 8,648
South
Mortality rate = 26 (15-37)
  Girls = 18 (5-32)
  Boys = 34 (17-50)
Deaths = 1,689
  Girls = 577
  Boys = 1,112
East
Mortality rate = 46 (34-58)
  Girls = 44 (28-60)
  Boys = 48 (30-65)
Deaths = 3,824
  Girls = 1,775
  Boys = 2,049
Northeast
Mortality rate = 39 (18-60)
  Girls = 33 (4-61)
  Boys = 46 (14-77)
Deaths = 538
  Girls = 223
  Boys = 316
North
Mortality rate = 54 (31-77)
  Girls = 60 (24-95)
  Boys = 49 (20-78)
Deaths = 1,576
  Girls = 794
  Boys = 782
Mortality Rate
(per 1,000,000 live births)
< 30
30-40
> 40
Table 2 – StudyDeaths, EstimatedNational-LevelDeaths, andMortalityRate (permillionpopulation)Attributable toChildhoodCancer,PresentedbySexand
Rural Location
No. of Study Deaths No. of Estimated Deaths, India 2010* Mortality Rate/Million Population (95% CI)
Overall Male Female Urban Rural Overall Male Female Urban Rural Overall Male Female
All cancers 189 117 72 29 160 13,700 8,600 5,100 2,500 11,200 37 (31-42)† 44 (36-52) 28 (22-35)
LL 94 61 33 9 85 6,900 4,500 2,400 600 6,300 18 (15-22) 23 (17-29) 13 (9-18)
Solid tumor 48 26 22 8 40 3,500 1,900 1,600 800 2,700 9 (7-12) 10 (6-13) 9 (5-12)
CNS tumor 47 30 17 12 35 3,400 2,300 1,200 1,200 2,200 9 (6-12) 12 (7-16) 7 (3-10)
NOTE. All-cancer mortality rate ratio (male:female) was 1.4 in the urban population and 1.7 in the rural population.
Abbreviation: LL, leukemia/lymphoma.
*Estimated deaths overall may not match subgroup totals due to rounding.
†Thirty-nine (95% CI, 33 to 44) per million population once age standardized against the world population for ages 0 to 14 years.
Fig 2 –
Estimated national-level
deaths and mortality rates
due to childhood cancer in
India by region.
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Although theexternal validity of ourmethodology is
impossible to determine given the absence of a
gold standard, the high rate of agreement between
the two reviewers (k = 0.75; 95%CI, 0.71 to 0.78)
provides reassurance.33Of note, the two reviewers
represented different areas of specialty: pediatric
cancer (the condition of interest) and pediatric
infectious disease (the most likely area of mis-
classification). Concordance between the two
specialists, therefore, lends greater face validity.
Similar techniques were used to identify deaths
attributable to rabies and may be used in future
studies of rare diseases.34
Additional limitations should be noted. The abso-
lute number of identified deaths was relatively
small, particularly when subdividedby geographic
region. Thus, although geographic variation in
childhood cancer mortality rates are plausible
given large socioeconomic differences across
India, they should be viewed as hypothesis gener-
ating only and await confirmation in future studies.
Similarly, disparities by cancer type should be
viewed with a degree of caution. The current co-
hort did not include childrenwho survived cancer;
therefore, we were unable to estimate childhood
cancer incidence rates in India. Finally, limita-
tions of verbal autopsies include a potential inability
to capture homeless populations, dependency
on caregiver recall accuracy, and appropriate
translation.
In conclusion, these analyses provide national
estimates of the burden of childhood cancer mor-
tality in India that are substantially higher than
those previously documented. These rates can be
used by childhood cancer advocates and policy-
makers to both encourage and design national
childhood cancer strategies and to improve the
outcomes of LMIC children with malignancies.
DOI: 10.1200/JGO.2015.000935
Published online on ascopubs.org/journal/jgo on April 13, 2016.
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Table 3 – Comparison of MDSMortality Rates (per million population) to Incidence andMortality Rates Derived From Various Indian Cancer Registries and
Vitals Statistics Data Bases and Select High-Income Country Cancer Registries
Incidence (Cancer Registries) or Mortality (MDS)
Leukemia/Lymphoma CNS Tumors All Cancers Mortality Rate
Male Female Male Female Male Female Male Female
Bhopal (central) 29 23 3 9 58 55 16 12
Delhi (north) 76 28 15 11 145 76 25 12
Bangalore (south) 51 32 17 10 87 69 17 16
Chennai (south) 92 47 17 10 150 97 23 26
Ahmedabad* (west) 19 14 6 0 51 23 12 36
Barshi (west) 42 24 9 4 69 53 46 42
Mumbai (west) 52 37 21 14 105 79 39 29
Northeast (northeast) 20 21 0 5 39 51 21 17
India MDS (95% CI) 23 (17 to 29) 13 (9 to 18) 12 (7 to 16) 7 (3 to 10) — — 44 (36 to 52) 28 (22 to 35)
United Kingdom† 61 36 147 33
Ontario, Canada‡ 62 31 144 28
NOTE. Incidence andmortality rates are standardized for the world population and expressed permillion population. Registry andmortality figures are taken from reports from the
National Cancer Registry Program of the Indian Council of Medical Research.7,21 Figures from Bangalore, Barshi, Bhopal, Delhi, and Mumbai are based on the period 2001 to
2003; northeast, 2003 to 2004; and Ahmedabad, 2004. Northeast comprises six population-based cancer registries: Aizawl District, Dibrugarh District, Kamrup Urban District,
Silchar Town, Imphal West District, and Sikkim State. Representing Indian regions as shown in Figure 2.
Abbreviation: MDS, Million Death Study.
*Ahmedabad district other than Ahmedabad urban.
†Incidence rates are based on the period 1996 to 2005 and mortality rates on 1995 to 2004.22,23
‡Based on the period 2000 to 2004.24
Table 4 – Highest Level of Health Care Accessed Before
Death Attributable to Childhood Cancer (n = 189)
No. (%)
Hospital 156 (82.5)
Governmental 23 (12.2)
Private 27 (14.3)
Other 106 (56.1)
Local health care worker 27 (14.3)
None/unknown 6 (3.2)
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